missing translation for 'onlineSavingsMsg'
Learn More

AUZ 454, MedChemExpress

Product Code. 16498867
Encompass_Preferred
Click to view available options
Quantity:
2 mg
5 mg
10 mg
25 mg
50 mg
Unit Size:
10mg
25mg
2mg
50mg
5mg
This item is not returnable. View return policy

Product Code. 16498867

Brand: Medchem Express HY15004

Please to purchase this item. Need a web account? Register with us today!

This item is not returnable. View return policy

MedChemExpress AUZ 454 (K03861) is a type II CDK2 inhibitor with Kd of 8.2 nM. AUZ 454 (K03861) inhibits CDK2 activity by competing with binding of activating cyclins.

AUZ 454 (K03861) is a type II CDK2 inhibitor with Kd of 8.2 nM. AUZ 454 (K03861) inhibits CDK2 activity by competing with binding of activating cyclins.

Specifications

Chemical Name or Material AUZ 454
CAS 853299-07-7
Color Off-White
Purity Grade Notes Research
Molecular Formula C24H26F3N7O2
Quantity 5 mg
Synonym K03861
Solubility Information DMSO : 250 mg/mL (498.50 mM; Need ultrasonic)
SMILES NC1=NC(OC2=CC=C(NC(NC3=CC(C(F)(F)F)=C(CN4CCN(C)CC4)C=C3)=O)C=C2)=CC=N1
Molecular Weight (g/mol) 501.5
Formula Weight 501.5
Percent Purity 98.91%
Grade Research
Physical Form Solid
For Use With (Application) Cancer-Kinase/protease
Show More Show Less

Research purposes only

Product Content Correction

The Fisher Scientific Encompass Program offers items which are not part of our distribution portfolio. These products typically do not have pictures or detailed descriptions. However, we are committed to improving your shopping experience. Please use the form below to provide feedback related to the content on this product.

Product Title

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.

Thank You! Your feedback has been submitted. Fisher Scientific is always working to improve our content for you. We appreciate your feedback.